CURRENT NEWS

• 22.08.2018
  LaVoieHealthScience Selected as a PRNews Platinum Award Finalist
• 22.08.2018
  Aduro Biotech Granted Composition of Matter Patent for Novel Human APRIL Binding Antibodies
• 22.08.2018
  CLYZ Labs Announces Seed Funding from Catapult Ventures to Develop Cancertain Test for Personalised Cancer Treatment
• 22.08.2018
  Avivagen Announces Vivamune Distribution Agreement for the GTA
• 22.08.2018
  Exact Sciences And Pfizer Enter Into U.S. Promotion Agreement For Cologuard
• 22.08.2018
  Phoenixville Hospital Installs Carestream Digital X-Ray Systems to Boost Image Quality, Streamline Workflow
• 22.08.2018
  AVITA Medical Announces Presentation of RECELL Device Effectiveness and Safety in Treatment of Thermal Burns at Premier U.S. Military Conference
• 22.08.2018
  Akaal Pharma Pty Ltd Announces Licensing Agreement for Its First-In-Class, Topical Spingosine-1-Phosphate-1 (S1P1) Receptor Modulator for Atopic Dermatitis and Psoriasis
• 22.08.2018
  Interim Report Q3 2017/18 (no. 32)
• 22.08.2018
  Twist Bioscience Responds to Agilent’s Latest Baseless Claims
• 22.08.2018
  Novimmune Submits Marketing Authorisation Application in Europe for Its Lead Drug Emapalumab
• 22.08.2018
  Inventiva Announces That It Has Been Informed Of The Modification Of The Call Option Agreement Concluded By Bvf Partners L.p.
• 22.08.2018
  Nuevolution AB (Publ) Announces Its Results for the Second Quarter of 2018
• 22.08.2018
  Easton Pharmaceuticals Begins Discussions to Acquire an Interest in an Operating Casino and Hotel Resort in Greece with Revenues in Excess of 60 Million Euro per Year
• 22.08.2018
  Warning Letter to Indian Drug Manufacturer Due to Various Deficiencies
• 22.08.2018
  Suven Life Sciences Secures Product & Process Patents in Canada and USA
• 22.08.2018
  CombiGene Announces a 75-Percent Guaranteed Preference Issue of Units Amounting to 31 Million Kronor
• 22.08.2018
  OptiBiotix Health Sees Revenues Build as Agreements Turn into Commercial Deals
• 22.08.2018
  CHEPLAPHARM takes over from Bristol-Myers Squibb, the global rights for Questran
• 22.08.2018
  Calyxt Names Biotech Veteran and Board of Directors Member Dr. Yves J. Ribeill as Interim CEO

Records per page:

Page

Total: 39333 records.